Daiichi Sankyo is giving up control of Ranbaxy Laboratories to Sun Pharma for $3.2 billion. Breakingviews' Peter Thal Larsen says it serves as a reminder of what can go wrong in overseas ventures.
1 / 26
Reuters Videos
Mon, Apr 7, 2014 12:37 AM EDT